As Expected, Nasdaq Delists Tripos From Global Market; Will Now Look to OTC | GenomeWeb
NEW YORK (GenomeWeb News) — The Nasdaq Global Market has delisted Tripos’ common stock as of this morning, Tripos said today.
 
Tripos said the exchange notified the company on Tuesday it would be removed from the exchange for non-compliance with market rules concerning minimum market capitalization and shareholder’s equity.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.